BSX241206P88000
- 0.10
- -0.02-16.67%
Boston Scientific Newsroom
Piper Sandler Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $95
Piper Sandler Sticks to Their Buy Rating for Boston Scientific (BSX)
Needham Maintains Boston Scientific(BSX.US) With Hold Rating
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Ventyx Biosciences (VTYX)
Boston Scientific Analyst Ratings
Piper Sandler Maintains Boston Scientific(BSX.US) With Buy Rating, Raises Target Price to $95
Piper Sandler Releases a Buy Rating on Boston Scientific (BSX)
A Quick Look at Today's Ratings for Boston Scientific(BSX.US), With a Forecast Between $98 to $100
Buy Rating on Boston Scientific: WATCHMAN Product's Expanding Market Potential and Revenue Growth
Boston Scientific Analyst Ratings
TD Cowen Keeps Their Buy Rating on Boston Scientific (BSX)
Optimistic Buy Rating for Boston Scientific Driven by Promising WATCHMAN FLX Trial Results
BofA Securities Maintains Boston Scientific(BSX.US) With Buy Rating
BofA Securities Maintains Boston Scientific(BSX.US) With Buy Rating
Bank of America Securities Keeps Their Buy Rating on Boston Scientific (BSX)
CCORF Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $98
TD Cowen Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $100
TD Cowen Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $100
A Quick Look at Today's Ratings for Boston Scientific(BSX.US), With a Forecast Between $98 to $100
Boston Scientific Analyst Ratings